5 ASX 200 shares rocketing to new 52-week highs on Tuesday

These stocks are making the most of the ASX 200's strong start to 2023.

| More on:
Five people are leaping in the shallows of the beach water as sunset shines gold on them.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This year has brought good tidings to the S&P/ASX 200 Index (ASX: XJO) and these five shares are among those making the most of it.

They've each jumped as much as 5.8% to reach their highest point in more than a year on Tuesday.

Meanwhile, the iconic index is up 0.44% at 7,490.4 points at the time of writing. That's 7.8% higher than it was at the start of the year.

Let's take a closer look at what's sent these market giants soaring today.

These ASX 200 shares are roaring to long-forgotten heights

The first ASX 200 share posting a new 52-week high is Clinuvel Pharmaceuticals Limited (ASX: CUV). Stock in the biopharmaceutical developer lifted 2.6% to reach $27.42 earlier today – the highest it's been since 2021.

It follows yesterday's news of the company's analogue adrenocorticotropic hormone (ACTH). It's aiming to submit a regulatory drug master file for the product in the second half of this year – an "aggressive goal" according to chief scientific officer Dr Dennis Wright.

Created with Highcharts 11.4.3Clinuvel Pharmaceuticals PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.com.au

The Mineral Resources Ltd (ASX: MIN) share price is also rocketing on Tuesday, hitting a new record high amid a broker upgrade. The stock peaked at $96.78 earlier today – a 5.8% gain.

UBS has reportedly upped its expectations for lithium. It now tips demand to outweigh supply in the near and medium term, the Australian Financial Review reports.

In response, it's slapped a buy rating on shares in the ASX 200 materials giant.

Created with Highcharts 11.4.3Mineral Resources PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.com.au

Meanwhile, the TechnologyOne Ltd (ASX: TNE) share price is in the green for a third consecutive day. It follows the release of the company's non-price-sensitive annual report on Thursday evening.

The tech stock reached an all-time high of $14.705 today – marking a 2% rise.

Created with Highcharts 11.4.3Technology One PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.com.au

ASX 200 travel giant Webjet Limited (ASX: WEB), on the other hand, popped then dropped today, hitting a post-pandemic high of $6.86 this morning before plunging into the red.

Today's peak saw the stock 1.2% higher than its previous close and around 170% higher than its 2020 low.

Created with Highcharts 11.4.3Web Travel Group Limited PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.com.au

Finally, shares in ASX 200 health imaging technology provider Pro Medicus Limited (ASX: PME) have continued to inch towards their all-time high today.

The stock has posted a new 52-week high for a third consecutive session. This time it peaked at $64.77 – a 2.4% jump.

Its gains might be a belated reaction to Friday's announcement, detailing a $25 million contract with the University of Washington.  

Created with Highcharts 11.4.3Pro Medicus PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.com.au

Should you invest $1,000 in Clinuvel Pharmaceuticals right now?

Before you buy Clinuvel Pharmaceuticals shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Clinuvel Pharmaceuticals wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 3 April 2025

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Pro Medicus. The Motley Fool Australia has recommended Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on 52-Week Highs

Five happy friends enjoying a party.
52-Week Highs

5 ASX 200 shares smashing new 52-week highs today

The Trump tariff relief rally has helped send these five ASX 200 shares to new 52-week highs.

Read more »

Arrows pointing upwards with a man pointing his finger at one.
52-Week Highs

3 ASX All Ords shares at new 52-week highs this Friday

These shares are proving to be a safe harbour this Friday.

Read more »

An excited man stretches his arms out above his head as he reaches a mountain peak representing two ASX 200 shares reaching multi-year high prices today
52-Week Highs

These 4 ASX 200 shares just clocked new 52-week highs today

These shares are standing out from the crowd today.

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
52-Week Highs

8 ASX 300 shares hitting new price highs today

New share price records were set despite the broader market trading in the red.

Read more »

Three people jumping cheerfully in clear sunny weather.
52-Week Highs

5 ASX 200 stocks hitting new 52-week highs today

These stocks are pushing higher today despite the shaky market...

Read more »

Piggy bank rocketing.
52-Week Highs

ASX shares lifting to 52-week highs on Friday

Do you own any of today's winners?

Read more »

Man raising both his arms in the air with a piggy bank on his lap, symbolising a record high.
52-Week Highs

These 9 ASX 200 shares just hit new 52-week highs

Let's check them out.

Read more »

Man on a ladder drawing an increasing line on a chalk board symbolising a rising share price.
52-Week Highs

6 ASX 200 shares hitting new 52-week highs today

These shares are defying today's market sell-off.

Read more »